How to manage a patient with hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyponatremia

Initial Assessment and Classification

Hyponatremia (serum sodium <135 mmol/L) requires immediate evaluation based on symptom severity, volume status, and serum osmolality to guide treatment and prevent complications. 1

  • Obtain serum and urine osmolality, urine sodium, urine electrolytes, serum uric acid, and assess extracellular fluid volume status through physical examination 1
  • Check serum creatinine, thyroid-stimulating hormone (TSH), and cortisol to exclude secondary causes 1
  • Classify severity: mild (130-135 mmol/L), moderate (120-129 mmol/L), severe (<120 mmol/L) 1, 2
  • Determine acuity: acute (<48 hours) versus chronic (>48 hours), as this fundamentally changes correction rates 1, 3
  • Assess volume status: hypovolemic (orthostatic hypotension, dry mucous membranes, decreased skin turgor), euvolemic (normal volume status), or hypervolemic (peripheral edema, ascites, jugular venous distention) 1

Treatment Based on Symptom Severity

Severe Symptomatic Hyponatremia (Medical Emergency)

For patients with severe symptoms (seizures, coma, altered mental status, respiratory distress), immediately administer 3% hypertonic saline with a target correction of 6 mmol/L over 6 hours or until symptoms resolve. 1, 4, 2

  • Give 100 mL boluses of 3% hypertonic saline over 10 minutes, repeatable up to three times at 10-minute intervals until symptoms improve 1
  • Never exceed total correction of 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1, 5, 4
  • Monitor serum sodium every 2 hours during initial correction phase 1
  • Admit to ICU for close monitoring during active correction 1

Moderate Symptomatic Hyponatremia

  • For patients with nausea, vomiting, confusion, headache, or gait instability, hospital admission is required for monitored correction 1, 6
  • Correction rate should be 4-6 mmol/L per day, not exceeding 8 mmol/L in 24 hours 1
  • Monitor serum sodium every 4-6 hours initially 1

Asymptomatic or Mildly Symptomatic Hyponatremia

  • Treatment focuses on addressing the underlying cause and volume status 1
  • Correction rate should be slower: 4-6 mmol/L per day maximum 1
  • Monitor serum sodium every 24-48 hours initially 1

Treatment Based on Volume Status

Hypovolemic Hyponatremia

Discontinue diuretics immediately and administer isotonic saline (0.9% NaCl) for volume repletion. 1, 2

  • Initial infusion rate: 15-20 mL/kg/h, then 4-14 mL/kg/h based on clinical response 1
  • Urine sodium <30 mmol/L predicts good response to saline infusion (positive predictive value 71-100%) 1
  • Continue isotonic saline until euvolemia is achieved 1
  • Maximum correction: 8 mmol/L in 24 hours 1

Euvolemic Hyponatremia (SIADH)

Fluid restriction to 1 L/day is the cornerstone of treatment for SIADH. 1, 4, 2

  • If no response to fluid restriction after 24-48 hours, add oral sodium chloride 100 mEq three times daily 1, 7
  • For persistent hyponatremia despite fluid restriction, consider vasopressin receptor antagonists (tolvaptan 15 mg once daily, titrate to 30-60 mg) 1, 5
  • Tolvaptan must be initiated in hospital with close sodium monitoring due to risk of overly rapid correction 5
  • For severe symptomatic SIADH, use 3% hypertonic saline as described above 1

Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)

Implement fluid restriction to 1-1.5 L/day for serum sodium <125 mmol/L. 1, 2

  • Discontinue diuretics temporarily if sodium <125 mmol/L 1
  • For cirrhotic patients, consider albumin infusion alongside fluid restriction 1
  • Avoid hypertonic saline unless life-threatening symptoms are present, as it worsens ascites and edema 1
  • Sodium restriction (2-2.5 g/day) is more effective than fluid restriction for weight loss in cirrhosis, as fluid follows sodium 1
  • For heart failure patients with persistent severe hyponatremia despite fluid restriction and guideline-directed medical therapy, consider short-term vasopressin antagonists 1

Special Populations and High-Risk Considerations

Patients with Advanced Liver Disease, Alcoholism, or Malnutrition

These patients require even more cautious correction at 4-6 mmol/L per day (maximum 8 mmol/L in 24 hours) due to significantly higher risk of osmotic demyelination syndrome. 1, 5, 4

  • Cirrhotic patients with hyponatremia have increased risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36) 1
  • Tolvaptan carries higher risk of gastrointestinal bleeding in cirrhosis (10% vs 2% placebo) 1

Neurosurgical Patients

Distinguish between SIADH and cerebral salt wasting (CSW), as they require opposite treatments. 1

  • SIADH: Euvolemic state, urine sodium >20-40 mmol/L, urine osmolality >300 mOsm/kg; treat with fluid restriction 1
  • CSW: True hypovolemia (CVP <6 cm H₂O), urine sodium >20 mmol/L despite volume depletion; treat with volume and sodium replacement, NOT fluid restriction 1
  • For CSW with severe symptoms, use 3% hypertonic saline plus fludrocortisone 0.1-0.2 mg daily 1
  • Never use fluid restriction in subarachnoid hemorrhage patients at risk of vasospasm 1
  • Consider fludrocortisone or hydrocortisone to prevent natriuresis in subarachnoid hemorrhage patients 1

Management of Overcorrection

If sodium correction exceeds 8 mmol/L in 24 hours, immediately discontinue current fluids and switch to D5W (5% dextrose in water). 1

  • Consider administering desmopressin to slow or reverse the rapid rise in serum sodium 1
  • Target reduction to bring total 24-hour correction to no more than 8 mmol/L from starting point 1
  • Monitor for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after rapid correction 1, 5

Critical Pitfalls to Avoid

  • Never correct chronic hyponatremia faster than 8 mmol/L in 24 hours—this causes osmotic demyelination syndrome 1, 5, 4
  • Never use fluid restriction in cerebral salt wasting—this worsens outcomes 1
  • Never use hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms 1
  • Never ignore mild hyponatremia (130-135 mmol/L) as clinically insignificant—it increases fall risk (21% vs 5%), mortality (60-fold increase with sodium <130 mmol/L), and cognitive impairment 1, 6, 4
  • Never use hypotonic fluids (lactated Ringer's, 0.45% saline) in patients with hyponatremia—they worsen the condition 1
  • Inadequate monitoring during active correction can lead to osmotic demyelination syndrome 1
  • Failing to recognize and treat the underlying cause leads to poor outcomes 1

Monitoring Requirements

  • Severe symptoms: Check serum sodium every 2 hours during initial correction 1
  • Moderate symptoms: Check serum sodium every 4-6 hours initially 1
  • Mild symptoms or asymptomatic: Check serum sodium every 24-48 hours initially 1
  • Monitor for neurological changes, volume status, and urine output throughout treatment 1
  • After discontinuation of treatment, resume fluid restriction and monitor for changes in sodium and volume status 5

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hyponatremia in the emergency department: an overview of diagnostic and therapeutic approach.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2024

Guideline

Hyponatremia Symptoms and Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oral Sodium Supplementation in Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.